KIT and breast carcinoma: It is a downstream target of c-KIT signalling in luminal epithelial stem/progenitor cells of the mammary gland (Regan et al., 2012; Tornillo et al., 2018) and also expressed in breast cancers, particularly TNBC (Choi et al., 2010; Hochgrafe et al., 2010; Molyneux et al., 2010).